Summit Master_rgb_png.png
Summit’s Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against Gonorrhoea
March 13, 2018 07:00 ET | Summit Therapeutics plc
OXFORD, United Kingdom and CAMBRIDGE, Mass., March 13, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) announces the discovery of a series of antibiotic compounds that kill...